02UG3JHSupplement Mitral Valve with Synthetic Substitute, Transapical, Percutaneous Approach
- Billable / Specific Code
02UG3JH is a billable ICD-10-PCS procedure code for Supplement Mitral Valve with Synthetic Substitute, Transapical, Percutaneous Approach. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRGs 266, 267. The root operation Supplement involves putting in or on biological or synthetic material that physically reinforces and/or augments the function of a portion of a body part.
Code Identity
PCS Table Breakdown
Each ICD-10-PCS code is built from seven characters, each an axis of the procedure. Hover or tap the icons for the official CMS definitions.
| Position | Designation | Value | Meaning |
|---|---|---|---|
| 1 | Section | 0 | Medical and Surgical |
| 2 | Body System | 2 | Heart and Great Vessels |
| 3 | Operation | U | Supplement |
| 4 | BodyPart | G | Mitral Valve |
| 5 | Approach | 3 | Percutaneous |
| 6 | Device | J | Synthetic Substitute |
| 7 | Qualifier | H | Transapical |
Code History
- 02UG3JZ — Supplement Mitral Valve with Synth Sub, Perc Approach
Similar Procedure Codes
Questions About 02UG3JH
Is 02UG3JH a billable code?
Yes. 02UG3JH is a complete seven-character ICD-10-PCS code, specific enough to report Supplement Mitral Valve with Synthetic Substitute, Transapical, Percutaneous Approach on inpatient claims from October 1, 2025 through September 30, 2026.
What do the characters in 02UG3JH mean?
02UG3JH breaks down character by character: the 1st character 0 is the Section (Medical and Surgical); the 2nd character 2 is the Body System (Heart and Great Vessels); the 3rd character U is the Operation (Supplement); the 4th character G is the BodyPart (Mitral Valve); the 5th character 3 is the Approach (Percutaneous); the 6th character J is the Device (Synthetic Substitute); the 7th character H is the Qualifier (Transapical).
What MS-DRG does 02UG3JH group to?
On an inpatient stay, Supplement Mitral Valve with Synthetic Substitute, Transapical, Percutaneous Approach maps to MS-DRGs 266, 267, with relative weights from 4.7608 to 6.1284. The MS-DRG sets the fixed Medicare payment for the stay.
